Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India
- 1 January 2009
- journal article
- case report
- Published by SAGE Publications in Tropical Doctor
- Vol. 39 (1) , 28-30
Abstract
Ciprofloxacin has become the antibiotic of choice for the treatment of typhoid fever with the emergence and worldwide spread of Salmonella enterica typhi strains resistant to chloramphenicol. However, the rampant use of ciprofloxacin gradually led to an increase in its minimum inhibitory concentration against S. enterica typhi. This threatened its therapeutic efficacy and resulted in the re-emergence of chloramphenicol-sensitive S. enterica typhi strains.Keywords
This publication has 5 references indexed in Scilit:
- Clinical Response and Outcome of Infection with Salmonella enterica Serotype Typhi with Decreased Susceptibility to Fluoroquinolones: a United States FoodNet Multicenter Retrospective Cohort StudyAntimicrobial Agents and Chemotherapy, 2008
- Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility ofSalmonella entericaserovar typhi and paratyphi AIndian Journal of Medical Microbiology, 2006
- Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in BangladeshEpidemiology and Infection, 2002
- Failure of Short-Course Ceftriaxone Chemotherapy for Multidrug-Resistant Typhoid Fever in Children: a Randomized Controlled Trial in PakistanAntimicrobial Agents and Chemotherapy, 2000
- Treatment of Typhoid Fever: Randomized Trial of a Three-Day Course of Ceftriaxone Versus a Fourteen-Day Course of ChloramphenicolThe American Journal of Tropical Medicine and Hygiene, 1995